ID   CAH12_HUMAN             Reviewed;         354 AA.
AC   O43570; B2RE24; Q53YE5; Q9BWG2;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   10-MAY-2017, entry version 167.
DE   RecName: Full=Carbonic anhydrase 12;
DE            EC=4.2.1.1;
DE   AltName: Full=Carbonate dehydratase XII;
DE   AltName: Full=Carbonic anhydrase XII;
DE            Short=CA-XII;
DE   AltName: Full=Tumor antigen HOM-RCC-3.1.3;
DE   Flags: Precursor;
GN   Name=CA12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHARACTERIZATION.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=9636197; DOI=10.1073/pnas.95.13.7608;
RA   Tuereci O., Sahin U., Vollmar E., Siemer S., Goettert E., Seitz G.,
RA   Parkkila A.-K., Shah G.N., Grubb J.H., Pfreundschuh M., Sly W.S.;
RT   "Human carbonic anhydrase XII: cDNA cloning, expression, and
RT   chromosomal localization of a carbonic anhydrase gene that is
RT   overexpressed in some renal cell cancers.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:7608-7613(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=9770531; DOI=10.1073/pnas.95.21.12596;
RA   Ivanov S.V., Kuzmin I., Wei M.-H., Pack S., Geil L., Johnson B.E.,
RA   Stanbridge E.J., Lerman M.I.;
RT   "Down-regulation of transmembrane carbonic anhydrases in renal cell
RT   carcinoma cell lines by wild-type von Hippel-Lindau transgenes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:12596-12601(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Eye, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   ENZYME REGULATION.
RX   PubMed=17705204; DOI=10.1002/anie.200701189;
RA   Koehler K., Hillebrecht A., Schulze Wischeler J., Innocenti A.,
RA   Heine A., Supuran C.T., Klebe G.;
RT   "Saccharin inhibits carbonic anhydrases: possible explanation for its
RT   unpleasant metallic aftertaste.";
RL   Angew. Chem. Int. Ed. Engl. 46:7697-7699(2007).
RN   [7]
RP   ENZYME REGULATION.
RX   PubMed=17314045; DOI=10.1016/j.bmcl.2007.01.113;
RA   Temperini C., Innocenti A., Guerri A., Scozzafava A., Rusconi S.,
RA   Supuran C.T.;
RT   "Phosph(on)ate as a zinc-binding group in metalloenzyme inhibitors: X-
RT   ray crystal structure of the antiviral drug foscarnet complexed to
RT   human carbonic anhydrase I.";
RL   Bioorg. Med. Chem. Lett. 17:2210-2215(2007).
RN   [8]
RP   ENZYME REGULATION.
RX   PubMed=17407288; DOI=10.1021/ja068359w;
RA   Srivastava D.K., Jude K.M., Banerjee A.L., Haldar M., Manokaran S.,
RA   Kooren J., Mallik S., Christianson D.W.;
RT   "Structural analysis of charge discrimination in the binding of
RT   inhibitors to human carbonic anhydrases I and II.";
RL   J. Am. Chem. Soc. 129:5528-5537(2007).
RN   [9]
RP   ENZYME REGULATION.
RX   PubMed=19186056; DOI=10.1016/j.bmcl.2009.01.038;
RA   Crocetti L., Maresca A., Temperini C., Hall R.A., Scozzafava A.,
RA   Muehlschlegel F.A., Supuran C.T.;
RT   "A thiabendazole sulfonamide shows potent inhibitory activity against
RT   mammalian and nematode alpha-carbonic anhydrases.";
RL   Bioorg. Med. Chem. Lett. 19:1371-1375(2009).
RN   [10]
RP   ENZYME REGULATION.
RX   PubMed=19206230; DOI=10.1021/ja809683v;
RA   Maresca A., Temperini C., Vu H., Pham N.B., Poulsen S.-A.,
RA   Scozzafava A., Quinn R.J., Supuran C.T.;
RT   "Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a
RT   new class of suicide inhibitors.";
RL   J. Am. Chem. Soc. 131:3057-3062(2009).
RN   [11]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND ENZYME REGULATION.
RX   PubMed=18618712; DOI=10.1002/prot.22144;
RA   Di Fiore A., Monti S.M., Hilvo M., Parkkila S., Romano V., Scaloni A.,
RA   Pedone C., Scozzafava A., Supuran C.T., De Simone G.;
RT   "Crystal structure of human carbonic anhydrase XIII and its complex
RT   with the inhibitor acetazolamide.";
RL   Proteins 74:164-175(2009).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF 30-291 IN COMPLEX WITH ZINC
RP   ION AND THE INHIBITOR ACETAZOLAMIDE, DISULFIDE BOND, AND SUBUNIT.
RX   PubMed=11493685; DOI=10.1073/pnas.161301298;
RA   Whittington D.A., Waheed A., Ulmasov B., Shah G.N., Grubb J.H.,
RA   Sly W.S., Christianson D.W.;
RT   "Crystal structure of the dimeric extracellular domain of human
RT   carbonic anhydrase XII, a bitopic membrane protein overexpressed in
RT   certain cancer tumor cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:9545-9550(2001).
RN   [13]
RP   VARIANT HCHLH LYS-143.
RX   PubMed=21035102; DOI=10.1016/j.ajhg.2010.10.008;
RA   Feldshtein M., Elkrinawi S., Yerushalmi B., Marcus B., Vullo D.,
RA   Romi H., Ofir R., Landau D., Sivan S., Supuran C.T., Birk O.S.;
RT   "Hyperchlorhidrosis caused by homozygous mutation in CA12, encoding
RT   carbonic anhydrase XII.";
RL   Am. J. Hum. Genet. 87:713-720(2010).
CC   -!- FUNCTION: Reversible hydration of carbon dioxide.
CC   -!- CATALYTIC ACTIVITY: H(2)CO(3) = CO(2) + H(2)O.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:11493685};
CC   -!- ENZYME REGULATION: Inhibited by coumarins, saccharin, sulfonamide
CC       derivatives such as acetazolamide (AZA), benzenesulfonamide and
CC       derivatives (4-carboxyethylbenzene-sulfonamide, 4-
CC       carboxyethylbenzene-sulfonamide ethyl ester, 4-(acetyl-2-
CC       aminoethyl)benzene-sulfonamide, 4-aminoethylbenzene-sulfonamide)
CC       and Foscarnet (phosphonoformate trisodium salt).
CC       {ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17407288,
CC       ECO:0000269|PubMed:17705204, ECO:0000269|PubMed:18618712,
CC       ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=12.0 mM for CO(2) {ECO:0000269|PubMed:18618712};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11493685}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O43570-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43570-2; Sequence=VSP_000772;
CC   -!- TISSUE SPECIFICITY: Highly expressed in colon, kidney, prostate,
CC       intestine and activated lymphocytes. Expressed at much higher
CC       levels in the renal cell cancers than in surrounding normal kidney
CC       tissue. Moderately expressed in pancreas, ovary and testis.
CC   -!- DISEASE: Hyperchlorhidrosis, isolated (HCHLH) [MIM:143860]: A
CC       disorder characterized by excessive sweating and increased sweat
CC       chloride levels. Affected individuals suffer from episodes of
CC       hyponatremic dehydration and report increased amounts of visible
CC       salt precipitates in sweat. {ECO:0000269|PubMed:21035102}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the alpha-carbonic anhydrase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF051882; AAC39789.1; -; mRNA.
DR   EMBL; AF037335; AAC63952.1; -; mRNA.
DR   EMBL; BT006656; AAP35302.1; -; mRNA.
DR   EMBL; AK315769; BAG38121.1; -; mRNA.
DR   EMBL; BC000278; AAH00278.1; -; mRNA.
DR   EMBL; BC011691; AAH11691.1; -; mRNA.
DR   EMBL; BC023981; AAH23981.1; -; mRNA.
DR   CCDS; CCDS10185.1; -. [O43570-1]
DR   CCDS; CCDS10186.1; -. [O43570-2]
DR   RefSeq; NP_001209.1; NM_001218.4. [O43570-1]
DR   RefSeq; NP_996808.1; NM_206925.2. [O43570-2]
DR   UniGene; Hs.210995; -.
DR   UniGene; Hs.603780; -.
DR   PDB; 1JCZ; X-ray; 1.55 A; A/B=30-291.
DR   PDB; 1JD0; X-ray; 1.50 A; A/B=30-291.
DR   PDB; 4HT2; X-ray; 1.45 A; A/B/C/D=30-291.
DR   PDB; 4KP5; X-ray; 1.45 A; A/B/C/D=30-291.
DR   PDB; 4KP8; X-ray; 1.80 A; A/B/C/D=30-291.
DR   PDB; 4Q0L; X-ray; 2.00 A; A/B/C/D=30-291.
DR   PDB; 4QJ0; X-ray; 1.55 A; A/B/C/D=30-291.
DR   PDB; 4QJO; X-ray; 1.80 A; A/B/C/D=30-291.
DR   PDB; 4QJW; X-ray; 1.55 A; A/B/C/D=30-291.
DR   PDB; 4WW8; X-ray; 1.42 A; A/B/C/D=30-291.
DR   PDBsum; 1JCZ; -.
DR   PDBsum; 1JD0; -.
DR   PDBsum; 4HT2; -.
DR   PDBsum; 4KP5; -.
DR   PDBsum; 4KP8; -.
DR   PDBsum; 4Q0L; -.
DR   PDBsum; 4QJ0; -.
DR   PDBsum; 4QJO; -.
DR   PDBsum; 4QJW; -.
DR   PDBsum; 4WW8; -.
DR   ProteinModelPortal; O43570; -.
DR   SMR; O43570; -.
DR   BioGrid; 107225; 8.
DR   IntAct; O43570; 10.
DR   MINT; MINT-1392387; -.
DR   STRING; 9606.ENSP00000178638; -.
DR   BindingDB; O43570; -.
DR   ChEMBL; CHEMBL3242; -.
DR   DrugBank; DB00562; Benzthiazide.
DR   DrugBank; DB08846; Ellagic Acid.
DR   DrugBank; DB00999; Hydrochlorothiazide.
DR   DrugBank; DB00774; Hydroflumethiazide.
DR   DrugBank; DB00909; Zonisamide.
DR   GuidetoPHARMACOLOGY; 2747; -.
DR   iPTMnet; O43570; -.
DR   PhosphoSitePlus; O43570; -.
DR   BioMuta; CA12; -.
DR   MaxQB; O43570; -.
DR   PaxDb; O43570; -.
DR   PeptideAtlas; O43570; -.
DR   PRIDE; O43570; -.
DR   DNASU; 771; -.
DR   Ensembl; ENST00000178638; ENSP00000178638; ENSG00000074410. [O43570-1]
DR   Ensembl; ENST00000344366; ENSP00000343088; ENSG00000074410. [O43570-2]
DR   GeneID; 771; -.
DR   KEGG; hsa:771; -.
DR   UCSC; uc002amc.4; human. [O43570-1]
DR   CTD; 771; -.
DR   DisGeNET; 771; -.
DR   GeneCards; CA12; -.
DR   HGNC; HGNC:1371; CA12.
DR   HPA; CAB025181; -.
DR   HPA; CAB062549; -.
DR   HPA; CAB068179; -.
DR   HPA; HPA008773; -.
DR   HPA; HPA073203; -.
DR   MalaCards; CA12; -.
DR   MIM; 143860; phenotype.
DR   MIM; 603263; gene.
DR   neXtProt; NX_O43570; -.
DR   OpenTargets; ENSG00000074410; -.
DR   PharmGKB; PA25987; -.
DR   eggNOG; KOG0382; Eukaryota.
DR   eggNOG; COG3338; LUCA.
DR   GeneTree; ENSGT00760000118915; -.
DR   HOGENOM; HOG000112637; -.
DR   HOVERGEN; HBG002837; -.
DR   InParanoid; O43570; -.
DR   KO; K01672; -.
DR   OMA; PPCYPTV; -.
DR   OrthoDB; EOG091G0XFM; -.
DR   PhylomeDB; O43570; -.
DR   TreeFam; TF316425; -.
DR   BRENDA; 4.2.1.1; 2681.
DR   Reactome; R-HSA-1475029; Reversible hydration of carbon dioxide.
DR   ChiTaRS; CA12; human.
DR   EvolutionaryTrace; O43570; -.
DR   GeneWiki; CA12; -.
DR   GenomeRNAi; 771; -.
DR   PRO; PR:O43570; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000074410; -.
DR   CleanEx; HS_CA12; -.
DR   ExpressionAtlas; O43570; baseline and differential.
DR   Genevisible; O43570; HS.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0004089; F:carbonate dehydratase activity; TAS:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; TAS:ProtInc.
DR   GO; GO:0015701; P:bicarbonate transport; TAS:Reactome.
DR   GO; GO:0055064; P:chloride ion homeostasis; IMP:UniProtKB.
DR   GO; GO:0006730; P:one-carbon metabolic process; IEA:InterPro.
DR   Gene3D; 3.10.200.10; -; 1.
DR   InterPro; IPR001148; Carbonic_anhydrase_a.
DR   InterPro; IPR023561; Carbonic_anhydrase_a-class.
DR   InterPro; IPR018338; Carbonic_anhydrase_a-class_CS.
DR   InterPro; IPR018430; Carbonic_anhydrase_CA12.
DR   PANTHER; PTHR18952; PTHR18952; 1.
DR   PANTHER; PTHR18952:SF160; PTHR18952:SF160; 1.
DR   Pfam; PF00194; Carb_anhydrase; 1.
DR   SMART; SM01057; Carb_anhydrase; 1.
DR   SUPFAM; SSF51069; SSF51069; 1.
DR   PROSITE; PS00162; ALPHA_CA_1; 1.
DR   PROSITE; PS51144; ALPHA_CA_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Disease mutation; Disulfide bond; Glycoprotein; Lyase; Membrane;
KW   Metal-binding; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Zinc.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    354       Carbonic anhydrase 12.
FT                                /FTId=PRO_0000004248.
FT   TOPO_DOM     25    301       Extracellular. {ECO:0000255}.
FT   TRANSMEM    302    322       Helical. {ECO:0000255}.
FT   TOPO_DOM    323    354       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       30    289       Alpha-carbonic anhydrase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01134}.
FT   REGION      226    227       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P00918}.
FT   ACT_SITE     94     94       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:P00918}.
FT   ACT_SITE    154    154       {ECO:0000250|UniProtKB:P00918}.
FT   METAL       119    119       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:11493685}.
FT   METAL       121    121       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:11493685}.
FT   METAL       145    145       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:11493685}.
FT   CARBOHYD     28     28       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     80     80       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    162    162       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     50    230       {ECO:0000269|PubMed:11493685}.
FT   VAR_SEQ     292    302       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_000772.
FT   VARIANT     143    143       E -> K (in HCHLH; mild reduction of
FT                                activity; mutant enzyme is highly
FT                                inhibited by acetazolamide and shows
FT                                higher sensitivity to inhibition by
FT                                anions compared to wild-type; the
FT                                mutation affects the chloride-mediated
FT                                negative feedback regulation of the
FT                                enzyme leading to excessive chloride
FT                                secretion in sweat; dbSNP:rs267606694).
FT                                {ECO:0000269|PubMed:21035102}.
FT                                /FTId=VAR_065292.
FT   CONFLICT    305    305       I -> T (in Ref. 4; BAG38121).
FT                                {ECO:0000305}.
FT   HELIX        36     38       {ECO:0000244|PDB:4WW8}.
FT   HELIX        40     42       {ECO:0000244|PDB:4WW8}.
FT   TURN         43     46       {ECO:0000244|PDB:4WW8}.
FT   HELIX        48     51       {ECO:0000244|PDB:4WW8}.
FT   STRAND       52     54       {ECO:0000244|PDB:4WW8}.
FT   HELIX        62     64       {ECO:0000244|PDB:4WW8}.
FT   STRAND       65     67       {ECO:0000244|PDB:4WW8}.
FT   STRAND       75     78       {ECO:0000244|PDB:4WW8}.
FT   STRAND       85     91       {ECO:0000244|PDB:4WW8}.
FT   STRAND       93     99       {ECO:0000244|PDB:4WW8}.
FT   STRAND      105    111       {ECO:0000244|PDB:4WW8}.
FT   STRAND      113    122       {ECO:0000244|PDB:4WW8}.
FT   STRAND      132    135       {ECO:0000244|PDB:4WW8}.
FT   STRAND      141    150       {ECO:0000244|PDB:4WW8}.
FT   TURN        151    153       {ECO:0000244|PDB:4WW8}.
FT   HELIX       157    160       {ECO:0000244|PDB:4WW8}.
FT   STRAND      167    176       {ECO:0000244|PDB:4WW8}.
FT   HELIX       181    187       {ECO:0000244|PDB:4WW8}.
FT   HELIX       188    193       {ECO:0000244|PDB:4WW8}.
FT   STRAND      199    203       {ECO:0000244|PDB:4WW8}.
FT   HELIX       207    210       {ECO:0000244|PDB:4WW8}.
FT   TURN        213    216       {ECO:0000244|PDB:4Q0L}.
FT   STRAND      218    223       {ECO:0000244|PDB:4WW8}.
FT   STRAND      234    241       {ECO:0000244|PDB:4WW8}.
FT   STRAND      243    245       {ECO:0000244|PDB:4WW8}.
FT   HELIX       247    255       {ECO:0000244|PDB:4WW8}.
FT   STRAND      258    260       {ECO:0000244|PDB:4WW8}.
FT   STRAND      285    288       {ECO:0000244|PDB:4WW8}.
SQ   SEQUENCE   354 AA;  39451 MW;  9016216BF2CA6C0C CRC64;
     MPRRSLHAAA VLLLVILKEQ PSSPAPVNGS KWTYFGPDGE NSWSKKYPSC GGLLQSPIDL
     HSDILQYDAS LTPLEFQGYN LSANKQFLLT NNGHSVKLNL PSDMHIQGLQ SRYSATQLHL
     HWGNPNDPHG SEHTVSGQHF AAELHIVHYN SDLYPDASTA SNKSEGLAVL AVLIEMGSFN
     PSYDKIFSHL QHVKYKGQEA FVPGFNIEEL LPERTAEYYR YRGSLTTPPC NPTVLWTVFR
     NPVQISQEQL LALETALYCT HMDDPSPREM INNFRQVQKF DERLVYTSFS QVQVCTAAGL
     SLGIILSLAL AGILGICIVV VVSIWLFRRK SIKKGDNKGV IYKPATKMET EAHA
//
